TDF Monotherapy Is Effective Regardless of Prior Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patients in China.

Mingxing HuangGuoli LinHong ShiYuankai WuYusheng JieZhe ZhuYutian Chong

Published in: BioMed research international (2017)

TDF monotherapy was effective regardless of prior NA experienced. Baseline HBV DNA was a key predictive factor for HBV DNA negative time in TDF monotherapy.

Keyphrases

hepatitis b virus
combination therapy
end stage renal disease
circulating tumor
open label
ejection fraction
cell free
chronic kidney disease
liver failure
peritoneal dialysis
prognostic factors
clinical trial
randomized controlled trial
replacement therapy